Clinical Trial

Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR

Study acronym: MARCH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients with functional mitral regurgitation classified as moderate to severe (3+) or severe (4+) that are symptomatic (NYHA Class II-IV) will be evaluated for treatment using the CathHELIX Transcatheter Mitral Annuloplasty System.
Trial Details
NCT Number NCT07188233
Lead Sponsor HVR Cardio Oy
Conditions Mitral Valve Regurgitation (Degenerative or Functional)
Enrollment 5 participants
Start Date 2024-11-16
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-23